Rznomics enters clinical trial collaboration with Roche to evaluate RZ-001 in combo with anti-PDL1 in liver cancer patients Ruchika Sharma15 Nov 2023 11:30 AM ISTSeongnam: Rznomics Inc., a South Korea based biopharmaceutical company specialized in the development of RNA-based gene therapeutics, has...
Roche receives USFDA Breakthrough Device Designation for Multiple Sclerosis test Elecsys NfL Ruchika Sharma10 Nov 2023 12:30 PM ISTElecsys NfL has the potential to help laboratories to scale MS testing on widely available, fully automated and standardised Roche cobas instruments...
Roche bags USFDA nod for Vabysmo to treat retinal vein occlusion Ruchika Sharma27 Oct 2023 11:32 AM IST"Vabysmo is a new treatment option for RVO that can help people preserve and improve their vision, with the added benefit of retinal drying," said...
Roche settles patent lawsuit against Biogen over biosimilar version of rheumatoid arthritis drug Actemra Ruchika Sharma26 Oct 2023 1:30 PM ISTBasel: Swiss pharmaceutical company Roche has settled a patent lawsuit against U.S. biotech firm Biogen over its biosimilar version of...
Roche acquires Telavant Holdings for USD 7.1 billion Ruchika Sharma24 Oct 2023 12:30 PM ISTBasel: Roche has announced the entry into a definitive agreement to acquire Telavant Holdings, Inc., a Roivant company, owned by Roivant Sciences Ltd....
Royalty Pharma to pay USD 1 billion for Roche SMA drug royalties Ruchika Sharma22 Oct 2023 10:00 AM ISTPTC said it plans to use the proceeds from the deal to pay back its debt from Blackstone Life Sciences and to fund planned operations.
Late-breaking data for Fenebrutinib show brain penetration, significant reduction in lesions in patients with relapsing multiple sclerosis: Roche Ruchika Sharma15 Oct 2023 9:00 AM ISTBasel: Roche has announced new data from the Phase II FENopta study showing that investigational, oral fenebrutinib is brain penetrant and reduces...
Vabysmo maintained vision improvements with extended treatment intervals up to 4 months for people with retinal vein occlusion in phase III studies: Roche Ruchika Sharma10 Oct 2023 2:30 PM ISTBasel: Roche has announced positive topline long-term results from the global phase III BALATON and COMINO studies, evaluating extended treatment...
Roche presents positive results for spinal muscular atrophy treatment Evrysdi in babies Ruchika Sharma8 Oct 2023 11:00 AM ISTBasel: Roche has presented positive results from the primary analysis of the ongoing RAINBOWFISH study assessing the efficacy and safety of Evrysdi...
Rishubh Gupta joins Roche Diagnostics as MD for India, neighbouring markets Roshni Dhar6 Oct 2023 2:32 PM ISTRoche Diagnostics India has said it has appointed Rishubh Gupta as its new Managing Director for India and neighbouring markets.Gupta will lead and...
Health Bulletin 05/October/2023 Roshni Dhar5 Oct 2023 4:53 PM ISTHere are the top health stories for the day:NExT exam for 2020 MBBS batch: Health Ministry forms committee to examine preparedness of medical...
Roche open to big acquisitions 'if it makes scientific and financial sense', CEO tells NZZ am Sonntag Ruchika Sharma11 Sept 2023 12:23 PM ISTZurich: Roche is open to making big acquisitions if they make "sense", Chief Executive Thomas Schinecker said, with the Swiss drugmaker...
